par Ignatiadis, Michail ;Trapp, Elisabeth;Goulioti, Theodora;Tryfonidis, Konstantinos;Pantel, Klaus;Repollet, Madeline;Janni, Wolfgang;Piccart-Gebhart, Martine ;Sotiriou, Christos ;Litière, Saskia;Pierga, Jean-Yves;Rack, Brigitte;Rothé, Françoise ;Riethdorf, Sabine;Decraene, Charles;Bonnefoi, Herve;Dittrich, Christian;Messina, Carlo;Beauvois, Melanie
Référence European journal of cancer, 63, page (97-104)
Publication Publié, 2016-08
Référence European journal of cancer, 63, page (97-104)
Publication Publié, 2016-08
Article révisé par les pairs
Titre: |
|
Auteur: | Ignatiadis, Michail; Trapp, Elisabeth; Goulioti, Theodora; Tryfonidis, Konstantinos; Pantel, Klaus; Repollet, Madeline; Janni, Wolfgang; Piccart-Gebhart, Martine; Sotiriou, Christos; Litière, Saskia; Pierga, Jean-Yves; Rack, Brigitte; Rothé, Françoise; Riethdorf, Sabine; Decraene, Charles; Bonnefoi, Herve; Dittrich, Christian; Messina, Carlo; Beauvois, Melanie |
Informations sur la publication: | European journal of cancer, 63, page (97-104) |
Statut de publication: | Publié, 2016-08 |
Sujet CREF: | Cancérologie |
Mots-clés: | Adjuvant treatment |
Breast cancer | |
CTC | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Antineoplastic Agents -- therapeutic use | |
Biomarkers, Tumor -- analysis | |
Biopsy -- methods | |
Breast Neoplasms -- diagnosis -- drug therapy | |
Clinical Trials as Topic | |
Female | |
Humans | |
Middle Aged | |
Neoplasm, Residual | |
Neoplastic Cells, Circulating -- pathology | |
Pilot Projects | |
Predictive Value of Tests | |
Prognosis | |
Trastuzumab -- therapeutic use | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:doi/10.1016/j.ejca.2016.04.024 | |
info:pii/S0959804916321220 | |
info:scp/84973569059 | |
info:pmid/27289552 |